O36.0139 Maternal care for anti-D [Rh] antibodies, third trimester, other fetus

Name of the Condition

• Maternal care for anti-D [Rh] antibodies, third trimester, other fetus
• ICD Code: O36.0139

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the third trimester who has anti-D (Rh) antibodies and is carrying multiple fetuses (excluding the first fetus). The focus is on managing the risk of hemolytic disease in the fetus or newborn, which can occur if any fetus is Rh-positive. Care includes assessment of antibody levels, fetal monitoring, and planning for potential interventions to prevent or treat complications.

Causes

The presence of anti-D antibodies typically results from prior exposure to Rh-positive blood, such as during a previous pregnancy with an Rh-positive fetus, blood transfusion, or trauma. These antibodies can cross the placenta and attack the red blood cells of an Rh-positive fetus, leading to hemolysis.

Risk Factors

• Previous pregnancy with an Rh-positive fetus
• Blood transfusion with Rh-positive blood
• Trauma or procedures (e.g., amniocentesis) during pregnancy that may cause fetal-maternal bleeding
• Unknown prior sensitization (e.g., from unrecognized fetal-maternal hemorrhage)

Symptoms

• No direct maternal symptoms; the condition is identified through laboratory testing
• Potential fetal complications (e.g., anemia, hydrops fetalis) may develop, but these are not maternal symptoms

Diagnosis

Diagnosis involves testing the mother’s blood for anti-D antibody levels and determining the Rh status of the fetuses. Fetal monitoring, such as ultrasound or Doppler studies, may be used to assess for signs of hemolytic disease. In multiple gestations, each fetus’s Rh status and antibody impact are evaluated separately.

Treatment Options

Treatment may include close monitoring of antibody titers and fetal well-being. Interventions could involve intrauterine transfusions for affected fetuses, administration of Rh immunoglobulin (if appropriate), or planning for early delivery if complications arise. Management is tailored to the specific risks of each fetus.

Prognosis and Follow-Up

With proper monitoring and intervention, outcomes for affected fetuses can be improved. Follow-up care focuses on ongoing assessment of antibody levels and fetal status until delivery. Postnatal care may be required for newborns with hemolytic disease.

Complications

Complications can include severe fetal anemia, hydrops fetalis, or stillbirth. In newborns, hemolytic disease may lead to jaundice, kernicterus, or the need for exchange transfusion.

Lifestyle & Prevention

Prevention of sensitization in Rh-negative women includes administering Rh immunoglobulin after events that may cause fetal-maternal bleeding (e.g., trauma, procedures). For women already sensitized, regular monitoring and adherence to medical recommendations are key.

When to Seek Professional Help

Seek care if there are signs of fetal distress (e.g., reduced movement) or if antibody levels rise significantly. Prompt evaluation is important for managing potential complications in multiple gestations.

Tips for Medical Coders

Use this code when documenting maternal care for anti-D antibodies in the third trimester of a multiple gestation, excluding the first fetus. Ensure documentation specifies the trimester and the presence of multiple fetuses to support code assignment. Note that this code is specific to "other fetus" in a multiple pregnancy and should not be used for singletons or the first fetus in a multiple set.